Comparing two heart-protecting solutions used during coronary bypass surgery, with MRI of heart muscle
Compares del Nido and blood cardioplegia for protecting the heart in bypass surgery.
Plain-language title generated from the registry record
Registry title: Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging
Key facts
- Where
- Zagreb, CroatiaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07637266, who can take part
Where in Croatia
- University Hospital Center ZagrebZagreb, CroatiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Klinički Bolnički Centar Zagreb
- Trial code
- NCT07637266
- Record updated
- 9 June 2026
- Original description
Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.Read full original descriptionShow less
Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging
Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.
Exclusion: Associated cardiac procedures; Left ventricular ejection fraction <30%; Off-pump coronary artery bypass grafting; Contraindications for MRI; Inability to provide consent.
Eligibility Criteria:; Patients with multivessel coronary artery disease scheduled for elective coronary artery bypass grafting.